National Genetics Institute (NGI) is a wholly-owned subsidiary of Laboratory Corporation of America® Holdings (LabCorp). NGI provides the global plasma industry with comprehensive donor qualification and source plasma donation screening services including advanced genetic testing and viral marker testing (VMT). For over 25 years, NGI has provided the global plasma industry with source plasma donation screening services for human immunodeficiency virus (HIV), hepatitis A, B, and C viruses (HAV, HBV, and HCV), parvovirus B19, West Nile virus and other infectious agents to ensure the safety of the plasma supply chain.
We have a long history of developing highly sensitive, multiplexed assays. In 2001, NGI received the very first FDA approvals for our HIV and HCV NAT assays. Our breakthrough technologies, combined with unique FDA-approved pooling algorithms, enable NGI to detect nucleic acid targets in individual samples and pools of hundreds of individual plasma samples (as large as 512), providing significant cost and turnaround time advantages to our global client base.
In 2019, we will be expanding our test menu to offer the most comprehensive plasma donor screening services in the industry, including nucleic acid testing (NAT), VMT, and Ancillary testing. We take pride in our unparalleled customer service, exceptional turnaround times, technical expertise and innovative test menu.
National Genetics Institute (NGI) is focused on providing high-quality donor qualification and source plasma donation screening services to the global plasma industry. We are an established leader in the field of nucleic acid screening services and are currently expanding our offerings to provide full-service donor screening support including viral marker testing (VMT) and ancillary testing services. We screen millions of plasma donations a year for infectious agents and have optimized our processes to ensure exceptional turn-around times (TAT).
The company also has provided numerous innovative laboratory solutions to pharmaceutical and biotechnology companies. Examples include the development, installation, maintenance, and staffing of large-scale laboratory robotic automation solutions (see www.Protedyne.com), and development, maintenance, and staffing of laboratory information management system (LIMS) applications and architecture, to support comprehensive donor screening of millions of donor samples per year. By leveraging the purchasing power of our parent company, LabCorp, we provide our clients with industry-leading testing services and cost-efficient solutions for donor plasma analysis.
National Genetics Institute (NGI) is licensed as a clinical laboratory provider by both state and federal agencies. It participates in a number of approved quality control programs, and holds active Biologics licenses from the US Food and Drug Administration (FDA) for the screening of plasma for blood-borne infectious agents. Our ~63,000 square foot laboratory facilities are located in Los Angeles, CA., within 10 miles of the Los Angeles International (LAX) airport.